Abstract:Crystallization phasing and obtaining high-quality crystals are bottleneck challenges for the X-ray crystallographic analysis of nucleic acids, especially when dynamic behavior is to be inferred from crystallographic B-factors. Crystallization of DNA duplexes, normally existing in the B-form in solution, is especially challenging, as the high salt used in many crystallization processes favors their transformation to A-form DNA duplexes. To address crystallization challenges while avoiding structural perturbation, we explored atom-specific incorporation to place a selenium atom on the 2′-β (arabino) position of the 2′-deoxyribose ring. This incorporation is expected to favor the B-form of a DNA duplex during crystallization. Here, we report the first synthesis of the β-2′-MeSe-thymidine (SeT) nucleoside, the corresponding Se-phosphoramidite, and Se-containing DNA oligonucleotides. We found that particular Se-DNAs form crystals that are surprisingly larger than we have often observed, having higher quality and giving improved diffraction resolution when compared to crystals from analogous standard oligonucleotides. Surprisingly, one duplex made from a self-complementary Se-containing oligonucleotide gave crystals 600 × 200 μm2 in size; this is 10–100 times larger in volume than the corresponding crystals grown from native DNA. CD and a solved crystal structure showed that the selenium in the β-orientation did not perturb the native structure and gave diffraction data from which dynamic information could be extracted. Crystals of this size are especially important for neutron diffraction studies. Moreover, we discovered that the high-quality Se-DNA crystals diffracted to 1.15 Å. The Se-derivatized structure was virtually identical with the native structure. These discoveries suggest a simple strategy to address other crystallization challenges in nucleic acid crystallography, a strategy whose scope deserves further exploration.

Investigation on the formation mechanism of twinned crystals of hypoxanthine-doped beta-phase anhydrous guanine microplatelets

Controlled Crystallization of Twinned Crystalline Guanine Microplatelets

Synthesis of Bio-Inspired Guanine Microplatelets: Morphological and Crystallographic Control

Doublet Nanoplate Structure of Phoroncidia Rubroargentea Spider-Derived Guanine Crystals for Enhanced Broadband Reflectivity

Controlled Crystallization of Anhydrous Guanine Β Nano-Platelets Via an Amorphous Precursor

Bio-Inspired Synthesis of Square-Shaped Anhydrous Hypoxanthine Nanoplatelet Crystals with Superior Optical Properties

Twin structure in the crystallite aggregation pattern

Synthesis of Porous Microplatelets of Α Form Anhydrous Guanine in DMSO/water Mixed Solvents

Reversible Crystal Phase Change Between Guanosine Dihydrate and Anhydrous Guanosine by a Heating–Cooling Process

Revealing the Crystal Structure of the Purine Base Xanthine with 3D Electron Diffraction

A Novel Tautomeric Polymorph of Anhydrous Guanine and Its Reversible Water Harvesting Property

X-ray Structure of Eleven New N,N′-Substituted Guanidines: Effect of Substituents on Tautomer Structure in the Solid State

The Research of G–Motif Construction and Chirality in Deoxyguanosine Monophosphate Nucleotide Complexes

Characterization, crystal structure and stability analysis of dianhydrodulcitol polymorphs

Two-dimensional Crystallization and Preliminary Structure Analysis of LHC-II from Cucumber and Spinach

Large‐Scale Synthesis of High‐Purity Isoguanosine and Resolution of its Crystal Structure by Microcrystal Electron Diffraction

One-dimensional assembly of β-form anhydrous guanine microrods

Guanosine hydrogels in focus: A comprehensive analysis through mid-infrared spectroscopy

2′-β-Selenium Atom on Thymidine to Control β-Form DNA Conformation and Large Crystal Formation

Microtwinning mechanism revealed by its orientation dependence and tension-compression asymmetry in γ′ precipitate-strengthened Ni-based superalloys

Crystal Structure of Thermoanaerobacter Tengcongensis Hypoxanthine‐guanine Phosphoribosyl Transferase L160I Mutant − Insights into Inhibitor Design